Business strategy Proposal -Biovectra – Analysis of Clinic Projects for BIOVECTRA Manufacturing Capacities

BIOVECTRA is a North American CDMO focusing on optimizing, adapting, and perfecting innovative technologies and drug substance development to deliver effective and novel solutions for pharmaceutical manufacturing. Challenges and opportunities include:
• Solving complex therapeutic challenges in collaboration with partners through contract development and manufacturing
• Offering products and services of exceptional caliber, on time and on budget
• Effective clinical to commercial scale production of high-quality regulated APIs and intermediates
This project is to determine mechanisms which could be used to target more specifically potential clients with molecules in clinical trials, based on either specific synthesis reactions or microbial expressions systems.

Faculty Supervisor:

Daniel Lafontaine

Student:

Partner:

BIOVECTRA Inc.

Discipline:

Life Sciences

Sector:

Biomanufacturing; Biotechnology

University:

Université de Sherbrooke

Program: